Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
|
|
- Kimberly Cain
- 6 years ago
- Views:
Transcription
1 CHEST Originl Reserch Inhled Corticosteroids nd the Risk of Pneumoni in People With Asthm A Cse-Control Study Trici McKeever, PhD ; Timothy W. Hrrison, MD ; Richrd Hubbrd, MD ; nd Dominick Shw, MD ASTHMA Bckground: In clinicl trils, the use of inhled corticosteroids is ssocited with n incresed risk of pneumoni in people with COPD, but whether the sme is true for people with sthm is not known. Methods: With the use of primry cre dt from The Helth Improvement Network, we identified people with sthm, nd from this cohort, we identified ptients with pneumoni or lower respirtory trct infection nd ge- nd sex-mtched control subjects. Conditionl logistic regression ws used to determine the ssocition between the dose nd type of inhled corticosteroid nd the risk of pneumoni or lower respirtory trct infection. Results: A dose-response reltionship ws found between the strength of inhled corticosteroid dose nd risk of pneumoni or lower respirtory trct infection ( P,.001 for trend) such tht fter djusting for confounders, people receiving the highest strength of inhled corticosteroid ( 1,000 m g) hd 2.04 (95% CI, ) incresed risk of pneumoni or lower respirtory trct infection compred with those with sthm who did not hve prescription for inhled corticosteroids within the previous 90 dys. Conclusions: People with sthm receiving inhled corticosteroids re t n incresed risk of pneumoni or lower respirtory infection, with those receiving higher doses being t greter risk. Pneumoni should be considered s possible side effect of inhled corticosteroids, nd the lowest possible dose of inhled corticosteroids should be used in the mngement of sthm. CHEST 2013; 144(6): Abbrevitions: ICS 5 inhled corticosteroid ; LRTI 5 lower respirtory trct infection Inhled corticosteroids (ICSs) re prescribed widely to people with sthm 1 nd COPD 2 to improve symptoms, mximize lung function, nd reduce excerbtion risk. Evidence suggests tht ICS use my be Mnuscript received April 10, 2013; revision ccepted July 31, Affilitions: From the Division of Epidemiology nd Public Helth (Drs McKeever nd Hubbrd) nd Respirtory Reserch Unit (Drs Hrrison nd Shw), University of Nottinghm, Nottinghm, Englnd. Funding/Support: The uthors hve reported to CHEST tht no funding ws received for this study. Correspondence to: Dominick Shw, MD, Respirtory Reserch Unit, University of Nottinghm, Edwrds Ln, Nottinghm, NG5 1PB, Englnd; e-mil: dominic.shw@nottinghm.c.uk 2013 Americn College of Chest Physicins. Reproduction of this rticle is prohibited without written permission from the Americn College of Chest Physicins. See online for more detils. DOI: /chest ssocited with n incresed risk of pneumoni in people with COPD. 3-5 Although sthm is n independent risk fctor for invsive pneumococcl disese, 6 it is not known whether ICSs re independently ssocited with n incresed risk of pneumoni in people with sthm. We set out to exmine whether ICSs re ssocited with n incresed risk of pneumoni or lower respirtory trct infection (LRTI) in people with sthm by using computerized primry cre dt nd mtched cse-control design. Mterils nd Methods We extrcted dt from The Helth Improvement Network dtbse ( This dtbse contins electronic medicl records of 9.1 million ptients collected from. 479 generl prctices in the United Kingdom. We identified cohort of 1788 Originl Reserch
2 people with recorded dignosis of sthm fter Jnury 4, 2004, ged 18 to 80 yers. We performed nested cse-control study in this cohort, with cses defined by the first-recorded dignosis of pneumoni or LRTI by previously defined Red codes for pneumoni. 7 The dte of the dignosis of pneumoni or LRTI ws considered the index dte. From the remining popultion of people with sthm, six control subjects per ptient were mtched on the bsis of sex nd ge t index dte (within 3 yers). Ptients nd control subjects with COPD were excluded from the dtset. Ethics pprovl to use dt from The Helth Improvement Network ws given by the NHS South-Est Multi-center Reserch Ethics Committee for studies tht use precollected, nonymized dt (reference number 07/H1102/103). The min hypothesis ws tht the risk of pneumoni or LRTI would be ssocited with the current use of ICS, nd for this reson, we initilly identified ll prescriptions for ICS up to 90 dys before the index dte. In the United Kingdom, the verge durtion of prescription is up to 90 dys. We grouped ICSs ccording to type s follows: beclomethsone dipropionte; fluticsone propionte, budesonide; nd combined group of ciclesonide nd mometsone furote tht ws not presented in ll nlyses becuse of smll numbers. Where the type of ICS ws chnged in the previous 90 dys, we defined exposure ccording to the lst prescription. We excluded individuls who were prescribed more thn one type of ICS inhler on the sme dy (n 5 78). To define the dose of ICS, we used the dose of drug delivered with ech inhltion becuse informtion on puffs prescribed per dy is recorded inconsistently in primry cre dtsets. To llow for different dose equivlence between drugs, budesonide ws considered equivlent to beclomethsone, nd dose multiplying fctor of 2 for fluticsone propionte ws used. For ech drug type, we defined high nd low dose bsed on cut point of 200 mg, except for fluticsone where we used cut point of 250 mg. These cut points represent the step t which long-cting b 2 -gonist is introduced ccording to UK sthm guidelines. 1 The priori confounders were smoking sttus (most recent recording) nd comorbidity s defined by the Chrlson Comorbidity Index score. 8 Other potentil confounders considered were influenz vccintion in the previous yer, number of courses of reliever inhlers in the previous yer (both totl nd seprted by short-cting b 2 -gonists nd long-cting b 2 -gonists), effect of orl corticosteroids (number of courses in the yer before the index dte), nd Townsend socioeconomic sttus score. We estimted the ssocition between ICS use nd pneumoni or LRTI by conditionl logistic regression nd vrious different exposures, including, in stepwise fshion, type of ICS, dose of ICS, nd combintion of type nd dose of ICS. We then djusted the models for priori confounders nd included other confounders if they ltered the ORs for the exposure nd outcome ssocition by. 10%. We performed number of sensitivity nlyses to determine whether the effect ws similr in different ptient popultions nd exmined whether the effect ws similr for the dignosis of pneumoni vs LRTI. We exmined the dt fter excluding ptients with bronchiectsis. We lso exmined the dt only in those who hd not chnged the type of inhler in the previous 90 dys nd included the number of short-cting nd long-cting inhlers in the pst yer seprtely in the model. All nlyses were completed with Stt 11 softwre (SttCorp LP). Results We identified 6,857 ptients with sthm nd pneumoni or LRTI nd 36,312 ge- nd sex-mtched control subjects from cohort of 359,172 people with sthm ( Tble 1 ). The men ge of the popultion ws 54 yers (rnge, yers). Ptients with sthm nd pneumoni or LRTI were more likely to smoke, hd higher Chrlson Comorbidity Index score (ie, more comorbid illness), nd were from lower socil clss compred with control subjects ( Tble 1 ). Ptients were more likely to hve received flu vccintion in the previous yer ( Tble 1 ) nd to use more reliever inhlers nd hd more prescriptions for orl steroids in the previous yer thn control subjects ( Tble 2 ). Ptients with sthm nd pneumoni or LRTI were more likely to hve prescription for ICS in the pst 90 dys thn control subjects ( Tble 2 ). After djusting for confounders, the OR for this ssocition ws 1.24 (95% CI, ) ( Tble 3 ). Steroid Type We exmined the risk of pneumoni or LRTI by ICS type. After djusting for confounders, budesonide use demonstrted smll incresed risk for pneumoni or LRTI (OR, 1.20; 95% CI, ; P 5.003). There ws higher risk of pneumoni or LRTI in ptients receiving fluticsone propionte (OR, 1.64; 95% CI, ; P,.001). None of the remining steroid inhlers ws ssocited with evidence of n incresed risk ( Tble 3 ). For fluticsone propionte the results were consistent if the 267 individuls who chnged their steroid inhler in the previous 90 dys were excluded. The results were lso similr when the cses were seprted by dignosis of LRTI or pneumoni; the OR for fluticsone propionte use nd risk of LRTI (n 53,410) ws 1.67 (95% CI, ) nd for the risk of pneumoni (n 53,447), 1.56 (95% CI, ). The results were consistent when ptients with bronchiectsis were excluded nd when the number of short- nd long-cting reliever inhlers were included seprtely in the model. Steroid Dose Of the ptients with sthm nd pneumoni or LRTI, 1.7% were prescribed the highest doses of ICSs ( 1,000 m g) compred with only 0.6% of the control subjects ( P,.001). There ws dose-response reltionship between strength of ICS nd infection risk ( P,.001 for trend) such tht fter djusting for confounders, ptients receiving the highest doses of ICSs were 2.04 (95% CI, ) times more likely to hve pneumoni or LRTI ( Tble 3 ). These results remined consistent in the vrious sensitivity nlyses nd fter excluding the 267 ptients with chnge of inhler in the previous 90 dys (OR for steroid dose 1,000 m g, 1.99; 95% CI, ; P,.001 for trend). When seprting the ptient cses journl.publictions.chestnet.org CHEST / 144 / 6 / DECEMBER
3 Tble 1 Demogrphic Dt for Ptients nd Control Subjects Chrcteristic Ptients (n 5 6,857) Control Subjects (n 5 36,312) Univrite OR (95% CI) Sex Mle 2,683 (39.1) 13,682 (37.7) Femle 4,174 (60.9) 22,630 (62.3) Age (men SD), y Smoking sttus Never 2,824 (41.2) 17,784 (49.0) 1.00 Ex 2,071 (30.2) 8,967 (24.7) 1.39 ( ) Current 1,621 (23.6) 6,890 (19.0) 1.55 ( ) Unknown 341 (5.0) 2,671 (7.4) 0.81 ( ) Chrlson Comorbidity Index score 0 3,132 (45.7) 21,822 (60.1) ,598 (37.9) 11,375 (31.3) 1.67 ( ) (10.5) 2,235 (6.2) 2.46 ( ) (4.0) 662 (1.8) 3.19 ( ) (1.5) 169 (0.5) 4.81 ( ) 5 30 (0.4) 49 (0.1) 5.13 ( ) Townsend score 1 high 1,452 (21.2) 8,651 (23.8) ,390 (20.3) 7,576 (20.9) 1.09 ( ) 3 1,312 (19.1) 7,024 (19.3) 1.12 ( ) 4 1,330 (19.4) 6,487 (17.9) 1.24 ( ) 5 low 1,043 (15.2) 4,409 (12.1) 1.43 ( ) Unknown 330 (4.8) 2,165 (6.0) 0.92 ( ) Influenz vccintion No 3,418 (49.8) 20,939 (57.7) 1.00 Yes 3,439 (50.2) 15,373 (42.3) 1.35 ( ) Dt re presented s No. (%) unless otherwise indicted. into pneumoni or LRTI, the effect ws stronger for pneumoni; for the highest doses of ICSs ( 1,000 mg), the OR for pneumoni (n 5 4,393) ws 2.37 (95% CI, ; P,.001 for trend) compred with the OR for LRTI (n 5 4,666) (1.75; 95% CI, ; P,.001 for trend). Steroid Dose nd Type Combined There ws significntly incresed risk of pneu mo ni or LRTI in ptients with sthm receiving beclom ethsone, budesonide, nd fluticsone, but only fluticsone when the nlysis ws restricted to those ged, 40 yers without bronchiectsis ( Tble 4 ). To control for sthm severity s confounder, we restricted the nlyses to ptients only receiving ICS, with those receiving low-dose beclomethsone s the bseline group. With this restricted dtset in the djusted nlyses, we found tht ptients prescribed high-dose beclomethsone were 24% more likely to hve n episode of pneumoni or LRTI (OR, 1.24; 95% CI, ). Prescriptions of low- nd highdose budesonide nd low- nd high-dose fluticsone incresed the risk of infection; the lrgest effect ws found in ptients prescribed high-dose fluticsone, who hd n 87% (OR, 1.87; 95% CI, ) incresed risk of hving pneumoni or LRTI compred with those prescribed low-dose beclomethsone ( Tble 5 ). Discussion To our knowledge, this study is the first to demonstrte reltionship between ICS use by type nd dose nd n incresed risk of pneumoni or LRTI in sthm. Ptients with sthm nd pneumoni or LRTI were more likely to be receiving high-dose ICS. These results re consistent for dignosis of both LRTI nd pneumoni nd re similr fter number of different sensitivity nlyses, including controlling for sthm severity. People with coexistent sthm nd COPD were excluded from the nlysis, nd the results remined consistent when restricted to people ged, 40 yers, negting ny residul confounding effect of COPD. There ws cler dose-response reltionship, with higher prescribed doses of ICS being ssocited with higher risk of infection. The only ICS ssocited with n incresed risk of LRTI or pneumoni cross ll nlyses ws fluticsone propionte. A mjor strength of this study is the popultion size. To our knowledge, it is the lrgest to dte, with 6,857 cses of pneumoni or LRTI identified. The ssocitions described remined consistent fter number of sensitivity nlyses, including n exmintion of effect in different ge popultions. The use of dt from primry cre records hs limittions. We cnnot confirm complince with ICS use or ssess device type. Furthermore, individuls my 1790 Originl Reserch
4 Tble 2 Study Popultion Mediction Use for Ptients nd Control Subjects Mediction Use Ptients (n 5 6,857) Control Subjects (n 5 36,312) Univrite OR (95% CI) Reliever use in the pst yer 0 2,002 (29.2) 16,547 (45.6) ,248 (18.2) 7,387 (20.3) 1.43 ( ) 3-6 1,338 (19.5) 5,938 (16.4) 1.91 ( ) ,194 (17.4) 3,888 (10.7) 2.59 ( ) 13 1,075 (15.7) 2,552 (7.0) 3.53 ( ) Orl steroid courses in the pst yer 0 5,061 (73.8) 32,324 (89.0) (8.1) 1,499 (4.1) 2.38 ( ) (7.2) 1,181 (3.3) 2.68 ( ) (5.7) 737 (2.0) 3.35 ( ) (5.3) 571 (1.6) 3.92 ( ) Most recent ICSs in the pst 90 d No steroids 3,432 (50.1) 24,143 (66.5) 1.00 Beclomethsone 1,214 (17.7) 5,743 (15.8) 1.46 ( ) Budesonide 536 (7.8) 2,065 (5.7) 1.82 ( ) Ciclesonide/mometsone 6 (0.1) 44 (0.1) 0.95 ( ) Fluticsone propionte 1,669 (24.3) 4317 (11.9) 2.71 ( ) ICS dose, m g 0 3,432 (50.1) 24,143 (66.5) 1.00, 200 1,227 (17.9) 5,592 (15.4) 1.53 ( ) (8.6) 2,400 (6.6) 1.71 ( ) (8.3) 1,896 (5.2) 2.07 ( ) (1.9) 441 (1.2) 2.07 ( ) (11.4) 1,626 (4.5) 3.36 ( ) 1, (1.7) 200 (0.6) 4.19 ( ) Dt re presented s No. (%) unless otherwise indicted. ICS 5 inhled corticosteroid. Ws not ble to determine strength in 25 individuls. be using drug tht ws prescribed before the 90-dy index period; however, this misclssifiction would bis the results towrd the null hypothesis. The present study lso shres similr limittion to studies of pneumoni in COPD, nmely tht pneumoni ws not confirmed rdiogrphiclly; however, the dignosis of pneumoni nd LRTI hs been previously shown to be resonbly ccurte. 7 Tble 3 Assocition Between Dose nd Type of ICS Use nd Risk of Pneumoni or LRTI (n 5 43,169) ICS Dose nd Type OR Adjusted OR 95% CI Adjusted OR b 95% CI Any ICS use in the pst 90 d No Yes ICS use in the pst 90 d No steroids Beclomethsone Budesonide Ciclesonide/mometsone Fluticsone ICS dose, c m g , , Individuls tking ciclesonide/mometsone were excluded from the nlyses becuse of smll numbers. LRTI 5 lower respirtory trct infection. See Tble 2 legend for expnsion of other bbrevition. Adjusted for number of relievers in the pst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer. b Restricted to individuls ged, 40 y who did not hve bronchiectsis nd did not chnge steroid in the previous 90 d nd djusted for number of relievers in the pst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer. c Ws not ble to determine strength in 25 individuls. journl.publictions.chestnet.org CHEST / 144 / 6 / DECEMBER
5 Tble 4 Anlysis Combining Type of ICS nd Dose With Risk of Pneumoni or LRTI (n 5 43,095) ICS Use in the Pst 90 d Cses, No. (%) Control Subjects No. (%) OR Adjusted OR 95% CI Adjusted OR b 95% CI No steroids 3,432 (50.1) 24,143 (66.5) Beclomethsone low dose 200 m g 1,031 (15.0) 5,101 (14.1) Beclomethsone high dose. 200 m g 183 (2.7) 642 (1.8) Budesonide low dose 200 m g 417 (6.1) 1,671 (4.6) Budesonide high dose. 200 m g 119 (1.7) 394 (1.1) Fluticsone low dose 250 m g 774 (11.3) 2,491 (6.9) Fluticsone high dose. 250 m g 895 (13.1) 1,826 (5.0) Individuls tking ciclesonide/mometsone were excluded from the nlyses becuse of smll numbers. See Tble 2 nd 3 legends for expnsion of bbrevitions. Adjusted for number of relievers in the pst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer. b Restricted to individuls ged, 40 y who did not hve bronchiectsis nd did not chnge steroid in the previous 90 d nd djusted for number of relievers in the pst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer. Lower lung function 9 is known to be ssocited with n incresed risk of pneumoni, with more severe sthm nd lower lung function crrying the highest risk; however, the incresed risk of pneumoni or LRTI remined despite correction for ge, smoking sttus, nd Chrlson Comorbidity Index score, reducing the effect of these limittions. We lso corrected for the number of orl steroids prescribed in the pst yer, which is ssocited with both disese severity nd decline in lung function, 10 nd for use of reliever inhlers, which is ssocited with n incresed risk of n dverse sthm outcome. 11 Becuse sthm severity is n independent risk fctor for pneumoni, 6,12 we ttempted to control for sthm severity s confounder by restricting the nly sis. We used low-dose beclomethsone s the bseline nd nlyzed only those ptients who received ICSs. The nlysis did not substntilly chnge the results, nd the dose-response trend remined unffected; however, we cknowledge tht it is impossible to fully remove severity s confounder. The possibility tht ICS my be ssocited with n incresed risk of pneumoni in obstructive lung disese greed with the results of the TORCH (Towrd Revolution in COPD Helth) study, 5 which exm- ined the potentil benefit of fluticsone propionte nd slmeterol on mortlity in COPD. The TORCH study reported 19% 3-yer rte of pneumoni in ptients receiving fluticsone t 1,000 m g/d, corresponding to significnt 1.6-fold increse over plcebo. There hve been few studies in sthm. O Byrne nd collegues 9 ssessed the risk of pneumoni in retrospective nlysis of budesonide use in sthm. The primry dtset ws ll double-blind, plcebocontrolled trils lsting t lest 3 months tht studied budesonide (26 trils, n 5 9,067 for budesonide nd n 5 5,926 for the comprtor); 62 cses of pneumoni were reported s either n dverse or serious dverse event for budesonide compred with 82 for the comprtor. In the primry dtset, the rte of pneumoni dverse events ws 0.5% (10 of 1,000 ptient-yers) for budesonide nd 1.2% (19.3 of 1,000 ptient-yers) for plcebo. The occurrence of pneumoni serious dverse events ws 0.15% for budesonide nd 0.13% for plcebo, resulting in hzrd rtio of 1.29 (95% CI, ), which is similr to the present OR of 1.10 for budesonide nd risk of pneumoni or LRTI. Overll, there ws no incresed risk with higher budesonide doses or ny difference between budesonide Tble 5 Restricted Anlysis of Assocition Between Type nd Dose of ICS in Ptients With Prescription for Steroids in the Pst 90 d nd Risk of Pneumoni or LRTI, With Low-Dose Beclomethsone s Control (n 5 9,324) ICS Use in the Pst 90 d OR Adjusted OR 95% CI Adjusted OR b 95% CI Beclomethsone low dose 200 m g Beclomethsone high dose. 200 m g Budesonide low dose 200 m g Budesonide high dose. 200 m g Fluticsone low dose 250 m g Fluticsone high dose. 250 m g Individuls tking ciclesonide/mometsone were excluded from the nlyses becuse of smll numbers. See Tble 2 nd 3 legends for expnsion of bbrevitions. Adjusted for number of relievers in the lst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer. b Restricted to individuls ged, 40 y who did not hve bronchiectsis nd did not chnge steroid in the previous 90 d nd djusted for number of relievers in the pst yer, Chrlson Comorbidity Index score, smoking, socil clss, nd use of orl steroids in the pst yer Originl Reserch
6 nd fluticsone propionte; however, pneumoni ws not the primry end point in the trils. Although the present dt show possible doseresponse reltionship, with higher doses of ICS being ssocited with n incresed risk of pneumoni or LRTI, the biologic mechnism explining the ssocition between risk of infection in sthm nd ICS is not cler. There is contrdictory evidence on the bil ity of ICS to influence bcteril numbers. Mouse models 13,14 nd in vitro studies of humn bronchil epithelil cells 15,16 hve demonstrted tht ICSs reduce bcteril lod or invsion, wheres steroid tretment cn rectivte chronic infection by typicl bcteri in vitro nd in niml models. 17,18 People receiving ICS for chronic respirtory disese hve lso been found to hve n incresed risk of nontuberculous mycobcteril infection 19,20 nd ltered irwy microbiot compred with norml subjects. 21 Studying the lung microbiot to delinete whether sthm itself or tretment with ICS lters the lung microbiome my help to nswer questions of custion. Conclusions We show tht ICSs re ssocited with n incresed risk of pneumoni nd LRTI in people with sthm. The results suggest tht the dose of ICS prescribed should be kept to the minimum necessry to tret symptoms nd tht the dose should be stepped down if the ptient is well controlled. Furthermore, prescribers should consider the possibility tht infection rther thn underlying sthm my be driving symptoms before incresing the ICS dose. This my be importnt before prescribers increse the ICS dose to tret recurring symptoms. A review nd met-nlysis of sthm studies involving ICS nd n explortion of the effect of ICS on the lung microbiot re now required. Acknowledgments Author contributions: Drs McKeever nd Shw hd full ccess to ll the dt in the study nd tke responsibility for the integrity of the dt nd the ccurcy of the dt nlysis. Dr McKeever: contributed to the study design, nlysis, nd review of the mnuscript. Dr Hrrison: contributed to the study design nd review of the mnuscript. Dr Hubbrd: contributed to the study design, nlysis, nd review of the mnuscript. Dr Shw: contributed to the study design nd writing of the first drft of the mnuscript. Finncil/nonfinncil disclosures: The uthors hve reported to CHEST the following conflicts of interest: Dr Hrrison hs received finncil support from Boehringer Ingelheim GmbH nd GlxoSmithKline to ttend scientific meetings nd honorrium pyments for dvisory bords from GlxoSmithKline, Npp Phrmceuticls Limited, nd Boehringer Ingelheim GmbH. Dr Hubbrd hs two Medicl Reserch Council grnts to investigte the cuses nd nturl history of lung fibrosis nd Roy Cstle clinicl fellowship wrd to study cre pthwys for people with lung cncer. Dr Hubbrd is the current GlxoSmithKline/British Lung Foundtion Professor of Respirtory Epidemiology. GlxoSmithKline hs cofunded cohort study of lung biomrkers for people with idiopthic pulmonry fibrosis for which Dr Hubbrd is copplicnt. Drs McKeever nd Shw hve reported tht no potentil conflicts of interest exist with ny compnies/orgniztions whose products or services my be discussed in this rticle. Other contributions: The uthors thnk Christopher Smith, PhD, for help in the preprtion of this mnuscript. References 1. British Thorcic Society nd Scottish Intercollegite Guidelines Network. British Guideline on the Mngement of Asthm. A Ntionl Clinicl Guideline. Edinburgh, Scotlnd; Ntionl Institute for Helth nd Clinicl Excellence. Chronic Obstructive Pulmonry Disese: Mngement of Chronic Obstructive Pulmonry Disese in Adults in Primry nd Secondry Cre. London, Englnd; Anzueto A, Ferguson GT, Feldmn G, et l. Effect of fluticsone propionte/slmeterol (250/50) on COPD excerbtions nd impct on ptient outcomes. COPD ;6(5): Rodrigo GJ, Cstro-Rodriguez JA, Plz V. Sfety nd efficcy of combined long-cting bet-gonists nd inhled corticosteroids vs long-cting bet-gonists monotherpy for stble COPD: systemtic review. Chest ;136(4): Crim C, Clverley PM, Anderson JA, et l. Pneumoni risk in COPD ptients receiving inhled corticosteroids lone or in combintion: TORCH study results. Eur Respir J ; 34 (3): Tlbot TR, Hrtert TV, Mitchel E, et l. Asthm s risk fctor for invsive pneumococcl disese. N Engl J Med ;352(20): Myles PR, McKeever TM, Pogson Z, Smith CJ, Hubbrd RB. The incidence of pneumoni using dt from computerized generl prctice dtbse. Epidemiol Infect ;137(5): Chrlson ME, Pompei P, Ales KL, McKenzie CR. A new method of clssifying prognostic comorbidity in longitudinl studies: development nd vlidtion. J Chronic Dis ; 40 (5): O Byrne PM, Pedersen S, Crlsson LG, et l. Risks of pneumoni in ptients with sthm tking inhled corticosteroids. Am J Respir Crit Cre Med ;183(5): Bi TR, Vonk JM, Postm DS, Boezen HM. Severe excerbtions predict excess lung function decline in sthm. Eur Respir J ;30(3): Suiss S, Ernst P, Boivin JF, et l. A cohort nlysis of excess mortlity in sthm nd the use of inhled bet-gonists. Am J Respir Crit Cre Med ;149(3 pt 1): Klemets P, Lyytikäinen O, Ruutu P, et l. Risk of invsive pneumococcl infections mong working ge dults with sthm. Thorx ;65(8): Mrtin RJ, Chu HW, Honour JM, Hrbeck RJ. Airwy inflmmtion nd bronchil hyperresponsiveness fter Mycoplsm pneumonie infection in murine model. Am J Respir Cell Mol Biol ;24(5): Hnsbro PM, Begley KW, Horvt JC, Gibson PG. Role of typicl bcteril infection of the lung in predisposition/protection of sthm. Phrmcol Ther ;101(3): Brbier M, Agustí A, Albertí S. Fluticsone propionte reduces bcteril irwy epithelil invsion. Eur Respir J ;32(5): Dowling RB, Johnson M, Cole PJ, Wilson R. Effect of fluticsone propionte nd slmeterol on Pseudomons eruginos infection of the respirtory mucos in vitro. Eur Respir J ;14(2): journl.publictions.chestnet.org CHEST / 144 / 6 / DECEMBER
7 17. Blott MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in humn monocytes nd enhnce their cpcity to induce IL-4 synthesis in CD4 1 lymphocytes. J Immunol ;158 (12 ): Litinen K, Luril AL, Leinonen M, Sikku P. Rectivtion of Chlmydi pneumonie infection in mice by cortisone tretment. Infect Immun ;64 (4 ): Hojo M, Iikur M, Hirno S, Sugiym H, Kobyshi N, Kudo K. Incresed risk of nontuberculous mycobcteril infection in sthmtic ptients using long-term inhled corticosteroid therpy. Respirology ;17 (1 ): Andréjk C, Nielsen R, Thomsen VØ, Duhut P, Sørensen HT, Thomsen RW. Chronic respirtory disese, inhled corticosteroids nd risk of non-tuberculous mycobcteriosis. Thorx ;68(3): Hilty M, Burke C, Pedro H, et l. Disordered microbil communities in sthmtic irwys. PLoS ONE ; 5 ( 1 ): e Originl Reserch
Inhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD
CHEST Originl Reserch Inhled Corticosteroid Is Associted With n Incresed Risk of TB in Ptients With COPD Jung-Hyun Kim, MD ; Ji-Soo Prk, MD ; Kyung-Ho Kim, MD ; Hye-Cheol Jeong, MD ; Eun-Kyung Kim, MD
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationUS Food and Drug Administration-Mandated Trials of Long-Acting b -Agonists Safety in Asthma. Samy Suissa, PhD ; and Amnon Ariel, MD, FCCP
CHEST Commentry US Food nd Drug Administrtion-Mndted Trils of Long-Acting b -Agonists Sfety in Asthm Will We Know the Answer? Smy Suiss, PhD ; nd Amnon Ariel, MD, FCCP For 2 decdes, long-cting b -gonists
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationIncreased Relative Mortality in Women With Severe Oxygen-Dependent COPD
CHEST Originl Reserch Incresed Reltive Mortlity in Women With Severe Oxygen-Dependent COPD Mgnus Ekström, MD ; Krl A. Frnklin, MD, PhD ; nd Kerstin E. Ström, MD, PhD COPD Bckground: Although the incidence
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationRisk of Misdiagnosis, Health-Related Quality of Life, and BMI in Patients Who Are Overweight With Doctor-Diagnosed Asthma
CHEST Originl Reserch Risk of Misdignosis, Helth-Relted Qulity of Life, nd BMI in Ptients Who Are Overweight With Doctor-Dignosed Asthm Stephen Scott, MB; Jcqueline Currie ; Pul Albert, MBBS ; Peter Clverley,
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationAddendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)
Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationMortality of patients with multiple sclerosis: a cohort study in UK primary care
Mortlity of ptients with multiple sclerosis: cohort study in UK primry cre The Hrvrd community hs mde this rticle openly vilble. Plese shre how this ccess benefits you. Your story mtters Cittion Jick,
More informationIsoetharinewith PhenylephrineAerosol in Asthma
J Clin Phrmcol. 1983; 23:82-88. Comprison of Fenoterol,Isoproterenol,od Isoethrineith PhenylephrineAerosol in Asthm GEORGE G. SPELLMAN, JR., M.D.,* BARBARA J. GRUEBEL, M.D., JOEL D. EPSTEIN, M.D., HAROLD
More informationEstimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain
Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr
More informationStart ORKAMBI today. INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION. Sydney Age 4
F O R H E A L T H C A R E P R O F E S S I O N A L S For ptients ge 2 yers nd older who re homozygous for the F508del muttion 1,2 Modify the course. Strt tody. Sydney Age 4 F508del/F508del INDICATIONS AND
More informationChronic obstructive pulmonary disease (COPD) is the third
METHODS Clims-Bsed Risk Model for First Severe COPD Excerbtion Richrd H. Stnford, PhrmD, MS; Arpit Ng, PhD, MBA, MS; Dougls W. Mpel, MD; Todd A. Lee, PhD; Richrd Rosiello, MD; Michel Schtz, MD; Frncis
More informationTrends in Mortality From COPD Among Adults in the United States
[ Originl Reserch COPD ] Trends in Mortlity From COPD Among Adults in the United Sttes Erl S. Ford, MD, MPH BACKGROUND: COPD imposes lrge public helth burden interntionlly nd in the United Sttes. The objective
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationWhat Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study. Ann Fam Med 2009;7: DOI: /afm.910.
Wht Drives Prescribing of Asthm Mediction to Children? A Multilevel Popultion-Bsed Study Mir G. P. Zuidgeest, PhrmD, PhD 1,3 Liset vn Dijk, PhD 2 Peter Spreeuwenberg, MA 2 Henriëtte A. Smit, MD, PhD 3
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationEstimated Prevalence and Economic Burden of Severe, Uncontrolled Asthma in the United States
Estimted Prevlence nd Economic Burden of Severe, Uncontrolled Asthm in the United Sttes Cheryl S. Hnkin 1 ; Amy Bronstone 1 ; Zhohui Wng 1 ; Mry Butti-Smll 2 ; Philip O. Buck 2 1 BioMedEcon, Moss Bech,
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationOutcome and severity of adult onset asthma Report from the obstructive lung disease in northern Sweden studies (OLIN)
Respirtory Medicine (2007) 101, 2370 2377 Outcome nd severity of dult onset sthm Report from the obstructive lung disese in northern Sweden studies (OLIN) Ev Rönmrk,b,, Anne Lindberg, Louise Wtson c, Bo
More informationSeasonal influenza vaccination programme country profile: Ireland
Sesonl influenz vccintion progrmme country profile: Irelnd 2012 13 Seson Bckground informtion Influenz immunistion policy nd generl fcts bout Irelnd Volume indices of GDP per cpit in 2011 nd 2013 (EU-
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationLongitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
Celli et l. Respirtory Reserch 2012, 13:66 RESEARCH Open Access Longitudinl inspirtory cpcity chnges in chronic ostructive pulmonry disese Brtolome R Celli 1*, Mrc Decrmer 2, Theodore Lystig 3, Steven
More informationMecadox. Improves pig performance in a wide range of health and growing conditions. (Carbadox) Talk With a Phibro Expert:
SWINE (Crbdox) Improves pig performnce in wide rnge of helth nd growing conditions The Advntge Over the yers, medicted feed dditive hs proven to be cost-effective mngement tool for improving pig performnce
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationDifferences in Disease Expression Between Primary Ciliary Dyskinesia and Cystic Fibrosis With and Without Pancreatic Insufficiency
CHEST Originl Reserch GENETIC AND DEVELOPMENTAL DISORDERS Differences in Disese Expression Between Primry Ciliry Dyskinesi nd Cystic Fibrosis With nd Without Pncretic Insufficiency Mlen Cohen-Cymberknoh,
More informationPrognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
Crcinogenesis, 2015, Vol. 36, No. 2, 243 248 doi:10.1093/crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of
More informationChilblains (pernio, perniosis) are cold-induced, painful or itching
Nifedipine vs Plcebo for Tretment of Chronic Chilblins: A Rndomized Controlled Tril Ibo H. Souwer, MD 1 Jcobus H. J. Bor, BSc (Mth) 2 Pul Smits, MD, PhD 3 Antoine L. M. Lgro-Jnssen, MD, PhD 1 1 Deprtment
More informationRapid communications Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012
Rpid communictions Incresed detection of Mycoplsm pneumonie infection in children in Englnd nd Wles, October 2011 to Jnury 2012 V J Chlker (vicki.chlker@hp.org.uk) 1, T Stocki 1, D Litt 1, A Berminghm
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationManagement and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence
Clinicin Summry Mentl Helth Eting Disorders Mngement nd Outcomes of Binge-Eting Disorder in Adults: Current Stte of the Evidence Focus of This Summry This is summry of systemtic review evluting the evidence
More informationRecall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study
Syddnsk Universitet Recll Bis in Childhood Atopic Diseses Among Adults in The Odense Adolescence Cohort Study Mørtz, Chrlotte G; Andersen, Klus Ejner; Bindslev-Jensen, Crsten Published in: Act Dermto-Venereologic
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationURINARY incontinence is an important and common
Urinry incontinence in older people in the community: neglected problem? Helen Stoddrt, Jenny Donovn, Elise Whitley, Deborh Shrp nd In Hrvey SUMMARY Bckground: The prevlence nd impct of urinry incontinence
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationbronchodilator, and airway calibre
Thorx 1982;37:423-429 Bronchil responsiveness to histmine: reltionship to diurnl vrition of pek flow rte, improvement fter bronchodiltor, nd irwy clibre G RYAN, KM LATIMER, J DOLOVICH, FE HARGREAVE From
More informationEffects of BMI on Static Lung Volumes in Patients With Airway Obstruction
CHEST Effects of BMI on Sttic Lung Volumes in Ptients With Airwy Obstruction Originl Reserch Denis E. O Donnell, MD, FCCP ; Athvudh Deesomchok, MD ; Yuk-Miu Lm, PhD ; Jordn A. Guenette, PhD ; Nprt Amornputtisthporn,
More informationSafety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Sfety of Ocrelizumb in Multiple Sclerosis: Updted Anlysis in Ptients With Relpsing nd Primry Progressive Multiple Sclerosis SL Huser, L Kppos, X Montlbn, H Koendgen, C Chognot, C Li, C Mrcillt, A Prdhn,
More informationFactors influencing help seeking in mentally distressed young adults: a cross-sectional survey
L Biddle, D Gunnell, D Shrp nd J L Donovn Fctors influencing help seeking in mentlly distressed young dults: cross-sectionl survey Lucy Biddle, Dvid Gunnell, Debbie Shrp nd Jenny L Donovn SUMMARY Bckground:
More informationThe Quality and Outcomes Framework (QOF) is a pay-for-performance
Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationRefining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
CHEST Originl Reserch Refining Clinicl Risk Strtifiction for Predicting Stroke nd Thromboembolism in Atril Fibrilltion Using Novel Risk Fctor-Bsed Approch The Euro Hert Survey on Atril Fibrilltion THROMBOEMBOLISM
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationReport of the Conference on Low Blood
1046 Report of the Conference on Low Blood Cholesterol: Mortlity Associtions Dvid Jcobs, PhD; Henry Blckburn, MD; Millicent Higgins, MD; Dwyne Reed, MD, PhD; Hiroysu Iso, MD; Grdner McMilln, MD, PhD; Jmes
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationDoes increasing physical activity reduce the excess risk of work disability among overweight individuals? 1
1 Does incresing physicl ctivity reduce the excess risk of work disbility mong overweight individuls? 1 by Jenni Ervsti, PhD, 2 Jkko Airksinen, PhD, Jn Pentti, MSc, Jussi Vhter, MD, PhD, Skri Suominen,
More informationUrinary Tract Infection in Men
C H A P T E R 1 9 Urinry Trct Infection in Men Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................623
More informationIn a key Academy of Managed Care Pharmacy (AMCP) Science and Innovation Theater Webinar,
C L I N I C A L B R I E F EDITORIAL & PRODUCTION Senior Clinicl Project Mnger Id Delmendo Clinicl Project Mnger Ted Pigeon Mnging Medicl Writer Angeli Szwed Associte Medicl Writers Elizbeth Kukielk, PhrmD,
More informationPotential for Interactions Between Dietary Supplements and Prescription Medications a
CLINICAL RESEARCH STUDY Potentil for Interctions Between Dietry Supplements nd Prescription Medictions Amit Sood, MD, MSc, Rich Sood, MD, b Frncis J. Brinker, ND, Rvneet Mnn, MBBS, c Lur L. Loehrer, Dietlind
More informationAnalysis of Regulatory of Interrelated Activity of Hepatocyte and Hepatitis B Viruses
Interntionl Journl of Biomedicl Mterils Reserch 8 6(): -7 http://www.sciencepublishinggroup.com/j/ijbmr doi:.648/j.ijbmr.86. ISSN: 33-756 (Print) ISSN: 33-7579 (Online) Anlysis of Regultory of Interrelted
More informationReports of cases of AIDS, HIV infection, and HIV/AIDS 1
Reports of cses of AIDS, HIV infection, nd HIV/AIDS 1 The HIV/AIDS Surveillnce Report is published nnully by the Division of HIV/AIDS Prevention Surveillnce nd Epidemiology, Ntionl Center for HIV, STD,
More informationStudies of the Mortality of Atomic Bomb Survivors, Report 14, : An Overview of Cancer and Noncancer Diseases
RADIATION RESEARCH 177, 229 243 (2012) 0033-7587/12 $15.00 Ó2012 by Rdition Reserch Society. All rights of reproduction in ny form reserved. DOI: 10.1667/RR2629.1 Studies of the Mortlity of Atomic Bomb
More informationAnalysis of Risk Factors for the Development of Incisional and Parastomal Hernias in Patients after Colorectal Surgery
Originl Article Journl of the Koren Society of J Koren Soc Coloproctol 2012;28(6):299-303 http://dx.doi.org/10.3393/jksc.2012.28.6.299 pissn 2093-7822 eissn 2093-7830 Anlysis of Risk Fctors for the Development
More informationPROVEN ANTICOCCIDIAL IN NEW FORMULATION
PROVEN ANTICOCCIDIAL IN NEW FORMULATION Coxidin 100 microgrnulte A coccidiosttic dditive for roilers, chickens rered for lying nd turkeys Contins 100 g of monensin sodium per kg Aville s homogenous grnules
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationSoybean Hulls as an Alternative Feed for Horses
Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationThe Association of Gender With Quality of Health in Peripheral Arterial Disease Following Peripheral Vascular Intervention
The Assocition of Gender With Qulity of Helth in Peripherl Arteril Disese Following Peripherl Vsculr Intervention Sudrshn Pudel, MD 1 ; Anwr Zitoun, MD 1 ; Sif Al-Njfi, MD 2 ; Ther Mus, MD 3 ; Susn Szpunr,
More informationMental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes
Fmily Prctice, 2015, Vol. 32, No. 3, 317 322 doi:10.1093/fmpr/cmv014 Advnce Access publiction 5 April 2015 Helth Service Reserch Mentl helth symptoms nd ptient-reported dibetes symptom burden: implictions
More informationProstate cancer is among the most common malignancies
Implictions of Evolving Delivery System Reforms for Prostte Cncer Cre Brent K. Hollenbeck, MD, MS; Mggie J. Bierlein, MS; Smuel R. Kufmn, MS; Lindsey Herrel, MD; Ted A. Skolrus, MD, MPH; Dvid C. Miller,
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationEpidemiological survey and analysis of asthma in children aged 0-14 years old in urban and rural areas of Chengdu region
Originl Article Epidemiologicl survey nd nlysis of sthm in children ged 0-14 yers old in urbn nd rurl res of Chengdu region Min Li 1, Qiong Zhng 2, Wei-Jun Shi 2, Ln Li 1, Yn Li 2, Ying Png 1, Bin Yo 1,
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationOriginal Article INTRODUCTION. Korean Diabetes J 2010;34: doi: /kdj pissn eissn
Originl Article doi: 1.493/kdj.21.34.6.34 pissn 1976-918 eissn 293-265 The Smll Rice Bowl-Bsed Mel Pln ws Effective t Reducing Dietry Energy Intke, Body Weight, nd Blood Glucose Levels in Koren Women with
More informationMultiple sclerosis (MS) affects approximately. Triaging Patients with Multiple Sclerosis in the Emergency Department. Room for Improvement
Systemtic Review of Tools for Anxiety in MS MS CARE DELIVERY: CHALLENGES AND INVATIONS Triging Ptients with Multiple Sclerosis in the Emergency Deprtment Room for Improvement Heshm Abboud, MD, PhD; Krin
More informationBMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationPlasma histamine and catecholamines in stable asthmatic subjects
Clinicl Science (1982) 62,661-665 66 1 Plsm histmine nd ctecholmines in stble sthmtic subjects P. J. BARNES, P. W. IND AND M. J. BROWN Deprtments of Medicine nd Clinicl Phrmcology, Royl Postgrdute Medicl
More information